Management of hypertension in relation to acute coronary syndromes and revascularisation.

Abstract:

:In patients with acute coronary syndromes (ACS), hypertension is common. The type of ACS and severity of hypertension would determine the treatment algorithm. In ST elevation myocardial infarction (MI), time to reperfusion is essential whereas in malignant hypertension the reduction of blood pressure to prevent end organ damage is the priority. Many therapeutic drugs available for ACS and hypertension are commonly used to treat both these conditions simultaneously. Once the ACS is treated medically, revascularization therapy is likely to be considered. Importantly, optimization of hypertension management may prevent subsequent complications. In this review, we discuss the frequency of hypertension and ACS as single clinical conditions, as well as combined presentations. The pathophysiology of myocardial perfusion in hypertensive patients and the effect of blood pressure (BP) normalization is discussed. This review focuses on treatment strategies from a non-interventional and interventional perspective. Finally, current medications used in treating hypertension in ACS will be compared with regards to their mode of action and prognostic value.

journal_name

Curr Pharm Des

authors

Kühl M,Lip GY,Varma C

doi

10.2174/138161207781663046

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

2556-66

issue

25

eissn

1381-6128

issn

1873-4286

journal_volume

13

pub_type

杂志文章,评审
  • Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature.

    abstract:BACKGROUND:Cardiovascular disease has been the leading cause of death in both sexes in developed countries for decades. In general, men and women share the same cardiovascular risk factors. However, in recent trials including both men and women sexspecific analyses have raised awareness of sex differences in cardiovasc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160309115318

    authors: Pedersen LR,Frestad D,Michelsen MM,Mygind ND,Rasmusen H,Suhrs HE,Prescott E

    更新日期:2016-01-01 00:00:00

  • Tissue engineering techniques in cardiac repair and disease modelling.

    abstract::Cell therapy has been proposed to treat patients with end-stage heart failure. However, it has been suggested that the significant mechanical forces in an often ischaemic, inflamed, biochemically hostile environment may cause poor cell survival and retention. It is hypothesised that tissue engineering techniques could...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990442

    authors: Rao C,Barratt H,Prodromakis T,Terracciano CM

    更新日期:2014-01-01 00:00:00

  • Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling.

    abstract::The survival of patients with pulmonary arterial hypertension is closely related with right ventricular function. During the progression of right ventricular remodeling, energetic metabolism shifts from oxidative mitochondrial metabolism to glycolysis. In normal physiological conditions, cardiomyocytes use major sourc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160614082712

    authors: Zhang R,Jing ZC

    更新日期:2016-01-01 00:00:00

  • Acid-extrusion from tissue: the interplay between membrane transporters and pH buffers.

    abstract::The acid-base balance of cells is related to the concentration of free H⁺ ions. These are highly reactive, and their intracellular concentration must be regulated to avoid detrimental effects to the cell. H⁺ ion dynamics are influenced by binding to chelator substances ('buffering'), and by the production, diffusion a...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799504920

    authors: Hulikova A,Harris AL,Vaughan-Jones RD,Swietach P

    更新日期:2012-01-01 00:00:00

  • Opiate-induced analgesia: contributions from mu, delta and kappa opioid receptors mouse mutants.

    abstract::The three opioid receptors, mu, delta and kappa all mediate analgesia, and knockout mice with opioid receptor deletion have proven unique tools to investigate in vivo opioid pharmacology. Since a few years, a number of new mouse lines have been engineered, with several distinct mutations of the mu receptor, to assess ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161281942140105163727

    authors: Gavériaux-Ruff C

    更新日期:2013-01-01 00:00:00

  • Human papillomavirus DNA and E6/E7 mRNA testing as triage in liquid-based cytology samples from primary screening.

    abstract::We estimated the frequency of detection of different human papillomavirus (HPV) types in women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL) cytology in a population-based primary screening programme. 247 liquid-based cytology (LBC) samples with A...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:

    authors: Andersson S,Mints M,Weiderpass E,Johansson B

    更新日期:2013-01-01 00:00:00

  • Nuclear Medicine Imaging in Fever of Unknown Origin: The New Paradigm.

    abstract::Fever of Unknown Origin, or FUO, is a challenging condition for patients and clinicians. In up to 50% of cases, no diagnosis is established. Patient workup begins with comprehensive history, physical examination and laboratory tests. Radionuclide imaging has been a second-line procedure. Gallium-67 citrate, which accu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666171129194507

    authors: Palestro CJ,Love C

    更新日期:2018-01-01 00:00:00

  • Beneficial effects of the Mediterranean diet on metabolic syndrome.

    abstract::The metabolic syndrome (MetS) represents a cluster of medical disorders, such as hyperglycemia, dyslipidemia, hypertension, and abdominal obesity that, when occurring together, increase the risk of developing cardiovascular disease. The role of food and nutrients in the aetiology of chronic diseases has become clearer...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612819666131206112144

    authors: Grosso G,Mistretta A,Marventano S,Purrello A,Vitaglione P,Calabrese G,Drago F,Galvano F

    更新日期:2014-01-01 00:00:00

  • Peripheral Corticotropin Releasing Factor Signaling Inhibits Gastric Emptying: Mechanisms of Action and Role in Stress-related Gastric Alterations of Motor Function.

    abstract::The activation of Corticotrophin Releasing-Factor (CRF) receptors in the brain is well established to coordinate the endocrine, behavioral, autonomic and visceral responses to stress. In addition, CRF receptors are also expressed within the gut where they exert biological actions and play a role in modulating stress-r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170228142428

    authors: Czimmer J,Tache Y

    更新日期:2017-01-01 00:00:00

  • The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders.

    abstract::Many, if not all, chronic medical, neurodegenerative and neuroprogressive illnesses are characterised by chronic immune activation, oxidative and nitrosative stress (O&NS) and systemic inflammation. These factors, notably elevated pro-inflammatory cytokines, activate indoleamine 2,3-dioxygenase (IDO) leading to an upr...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151215102420

    authors: Morris G,Carvalho AF,Anderson G,Galecki P,Maes M

    更新日期:2016-01-01 00:00:00

  • A redox pathway leading to the alkylation of nucleic acids by doxorubicin and related anthracyclines: application to the design of antitumor drugs for resistant cancer.

    abstract::Doxorubicin has been a constituent of antitumor drug protocols for a broad spectrum of cancers for more than two decades. Side effects and resistance continue to be important limitations. Drug targets responsible for both side effects and anti-tumor activity are cell membrane receptors, cell membrane lipids, nucleic a...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Taatjes DJ,Fenick DJ,Gaudiano G,Koch TH

    更新日期:1998-06-01 00:00:00

  • Fluoroquinolones as chemotherapeutics against mycobacterial infections.

    abstract::The antimicrobial agents used in the treatment of mycobacterial infections have remained largely unchanged for several decades. Primary treatment of tuberculosis relies on four drugs, isoniazid, a rifamycin, pyrazinamide, and ethambutol (or streptomycin), and generally results in >95% cure in uncomplicated tuberculosi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043383296

    authors: Jacobs MR

    更新日期:2004-01-01 00:00:00

  • Molecular recognition explored by a statistical-mechanics theory of liquids.

    abstract::"Molecular recognition" is one of the most important molecular processes for living systems in order to maintain their life, since most of the biological functions are initiated with the process. Understanding of the process is also important for designing a new drug. Firstly, it is important to find a target of a dru...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211796355100

    authors: Phongphanphanee S,Yoshida N,Hirata F

    更新日期:2011-01-01 00:00:00

  • A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management.

    abstract::Severe acute respiratory syndrome-coronavirus (SARS-CoV-2, or COVID-19 virus) is a worldwide pandemic pathogen infecting 210 territories. It belongs to the family coronaviriadae and the order Nidovirales. The SARS-CoV-2 virus is a positive-sense single-stranded RNA enveloped virus that includes spike proteins projecti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666201222162509

    authors: Ahmed H,Sayed A,Munir M,Elberry MH,Sayed IM,Kamal MA,Negida A,Ebada MA,Bahbah EI

    更新日期:2020-12-22 00:00:00

  • Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases.

    abstract:BACKGROUND:Polyphenols are bioactive compounds that can be found mostly in foods like fruits, cereals, vegetables, dry legumes, chocolate and beverages such as coffee, tea and wine. They are extensively used in the prevention and treatment of cardiovascular disease (CVD) providing protection against many chronic illnes...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180130112652

    authors: Giglio RV,Patti AM,Cicero AFG,Lippi G,Rizzo M,Toth PP,Banach M

    更新日期:2018-01-01 00:00:00

  • Depression in older persons with mobility limitations.

    abstract::The impact of depression on physical disability is undisputed. There is convincing evidence that depression increases the subsequent risk for physical disability and, in turn, physical disability results in increased depressive symptoms. Moreover, depression affects also the earlier stages of the disablement process (...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113196660060

    authors: Milaneschi Y,Penninx BW

    更新日期:2014-01-01 00:00:00

  • The Applications of 3D Printing in Pulmonary Drug Delivery and Treatment of Respiratory Disorders.

    abstract:BACKGROUND:Pulmonary diseases are the third leading cause of morbidity worldwide, however treatment and diagnosis of these diseases continue to be challenging due to the complex anatomical structure as well as physiological processes in the lungs. METHODS:3D printing is progressively finding new avenues in the medical...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666181206123414

    authors: Haque S,Md S,Whittaker M,Kaminskas LM

    更新日期:2018-01-01 00:00:00

  • Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

    abstract:BACKGROUND:There are controversial results available about using angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) and the development of cancers or improvement of clinical outcomes. Studies reported that using ACEI/ARB may enhance the development of hepatocellular carcinoma (HCC...

    journal_title:Current pharmaceutical design

    pub_type: meta分析

    doi:10.2174/1381612826666200713165018

    authors: Asgharzadeh F,Jafarzadeh-Esfehani R,Hassanian SM,Ferns GA,Avan A,Khazaei M

    更新日期:2020-01-01 00:00:00

  • Treatment of hypertensive complications in pregnancy.

    abstract::Hypertension is the most common medical disorder during pregnancy. Approximately 70 percent of women diagnosed with hypertension during pregnancy will have gestational hypertension-preeclampsia. The term gestational hypertension-preeclampsia is used to describe a wide spectrum of patients who may have only mild elevat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612053381864

    authors: Coppage KH,Sibai BM

    更新日期:2005-01-01 00:00:00

  • Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance.

    abstract::Multidrug resistance (MDR) is a phenomenon through which tumor cells develop resistance against the cytotoxic effects of various structurally and mechanistically unrelated chemotherapeutic agents. The most consistent feature in MDR is overexpression and/or overactivity of ATP-dependent drug efflux transporters. Other ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151124234417

    authors: Ghandadi M,Sahebkar A

    更新日期:2016-01-01 00:00:00

  • Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease.

    abstract::Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with premature mortality, severe morbidity, and functional impairment leading to considerable financial burden for both patients and society. Since disease progression and complications can differ from one patient to another, genetic markers are of...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140825123407

    authors: Rodriguez-Rodriguez L,López-Mejias R,Fernández-Gutiérrez B,Balsa A,González-Gay MA,Martín J

    更新日期:2015-01-01 00:00:00

  • Physiology and therapeutic potential of the thymic peptide thymulin.

    abstract::Thymulin is a thymic hormone exclusively produced by the epithelial cells of the thymus. After its discovery and initial characterization in the '70s, it was demonstrated that the production and secretion of thymulin are strongly influenced by the neuro-endocrine system. Conversely, a growing body of evidence, to be r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140130211157

    authors: Reggiani PC,Schwerdt JI,Console GM,Roggero EA,Dardenne M,Goya RG

    更新日期:2014-01-01 00:00:00

  • Polyphenols: Inflammation.

    abstract:BACKGROUND:Polyphenols widely distributed in plants, fruits and vegetables have received considerable attention on account of their physiological functions, including their antioxidant and anti-inflammatory properties. Some antioxidant components of cacao liquor prepared from fermented and roasted cacao beans, which is...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666171109104141

    authors: Natsume M

    更新日期:2018-01-01 00:00:00

  • Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

    abstract::Cellular uptake of therapeutic oligonucleotides and subsequent intracellular trafficking to their target sites represents the major technical hurdle for the biological effectiveness of these potential drugs. Accordingly, laboratories worldwide focus on the development of suitable delivery systems. Among the different ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786898806

    authors: Laufer SD,Restle T

    更新日期:2008-01-01 00:00:00

  • New perspectives in glioma immunotherapy.

    abstract::Glioblastoma (GBM) is a deadly tumor, which in spite of surgery and radio/chemotherapy frequently undergoes relapses related to the infiltration of the normal parenchyma and to resistance to cytotoxic and radiation therapy. Immunotherapy may represent a promising approach, which may complement existing therapies with ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211797249206

    authors: Daga A,Bottino C,Castriconi R,Gangemi R,Ferrini S

    更新日期:2011-01-01 00:00:00

  • Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning.

    abstract::An important goal of biomedical research is to translate basic research findings into practical clinical implementation. Despite the advances in the technology used in drug discovery, the development of drugs for central nervous system diseases remains challenging. The failure rate for new drugs targeting important ce...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200224112534

    authors: Morofuji Y,Nakagawa S

    更新日期:2020-01-01 00:00:00

  • The role of mast cells in the structural alterations of the airways as a potential mechanism in the pathogenesis of severe asthma.

    abstract::Mast cells, traditionally regarded as effector cells of the immune system, have more recently been demonstrated to be key figures in initiating, developing and sustaining complex pathophysiological processes underlying asthma and other allergic diseases. Asthma is characterised by airway inflammation alongside a distu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795428975

    authors: Carter RJ,Bradding P

    更新日期:2011-01-01 00:00:00

  • ABO-Incompatible Liver Transplantation: State of Art and Future Perspectives.

    abstract::ABO-incompatible (ABO-I) liver transplantation (LT) has been limited due to the increased rate of complications, including severe cellular and antibody-mediated rejection, hepatic necrosis, hepatic artery thrombosis, and biliary complications. However, several strategies for reducing preformed anti-donor ABO antibodie...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200506094539

    authors: Cheng CH,Lee CF,Wang YC,Wu TH,Wu TJ,Chou HS,Chan KM,Lee WC

    更新日期:2020-01-01 00:00:00

  • Computational Modeling and Experimental Facts of Mixed Self- Assembly Systems.

    abstract::The formation of liposomes, nanoparticle micelles, and related systems by mixtures of drugs and/or surfactants is of major relevance for the design of drug delivery systems. We can design new systems using different compounds. Traditionally these systems are created by trial and error using experimental data. However,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160513150054

    authors: Messina PV,Besada-Porto JM,Rial R,González-Díaz H,Ruso JM

    更新日期:2016-01-01 00:00:00

  • Drug release from ordered mesoporous silicas.

    abstract::The state-of-the-art in the investigation of drugs release from Silica-based ordered Mesoporous Materials (SMMs) is reviewed. First, the SMM systems used like host matrixes are described. Then, the model drugs studied until now, including their pharmacological action, structure and the mesoporous matrix employed for e...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151106121419

    authors: Doadrio AL,Salinas AJ,Sánchez-Montero JM,Vallet-Regí M

    更新日期:2015-01-01 00:00:00